KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on Sales

Jazz Pharmaceuticals (JAZZ) Times Interest Earned (2016 - 2017)

Historic Times Interest Earned for Jazz Pharmaceuticals (JAZZ) over the last 5 years, with Q3 2013 value amounting to $163.78.

  • Jazz Pharmaceuticals' Times Interest Earned rose 22548.39% to $163.78 in Q3 2013 from the same period last year, while for Jun 2014 it was $301.72, marking a year-over-year increase of 29143.87%. This contributed to the annual value of $200.54 for FY2013, which is 26692.82% up from last year.
  • As of Q3 2013, Jazz Pharmaceuticals' Times Interest Earned stood at $163.78, which was up 22548.39% from $200.17 recorded in Q2 2013.
  • Jazz Pharmaceuticals' 5-year Times Interest Earned high stood at $200.17 for Q2 2013, and its period low was -$251.61 during Q1 2013.
  • Moreover, its 5-year median value for Times Interest Earned was $12.07 (2010), whereas its average is $30.23.
  • In the last 5 years, Jazz Pharmaceuticals' Times Interest Earned tumbled by 14886.56% in 2010 and then skyrocketed by 217570.47% in 2011.
  • Over the past 5 years, Jazz Pharmaceuticals' Times Interest Earned (Quarter) stood at $4.49 in 2009, then plummeted by 148.87% to -$2.19 in 2010, then soared by 2444.32% to $51.38 in 2011, then tumbled by 42.05% to $29.77 in 2012, then soared by 450.07% to $163.78 in 2013.
  • Its last three reported values are $163.78 in Q3 2013, $200.17 for Q2 2013, and -$251.61 during Q1 2013.